Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma

Ductal carcinoma in situ (DCIS) is considered a non-invasive precursor to breast cancer, and although associated with an increased risk of developing invasive disease, many women with DCIS will never progress beyond their in situ diagnosis. The path from normal duct to invasive ductal carcinoma (IDC...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebbeck, Clare A., Xian, Jian, Bornelöv, Susanne, Geradts, Joseph, Hobeika, Amy, Geiger, Heather, Alvarez, Jose Franco, Rozhkova, Elena, Nicholls, Ashley, Robine, Nicolas, Lyerly, Herbert K., Hannon, Gregory J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192778/
https://www.ncbi.nlm.nih.gov/pubmed/35697697
http://dx.doi.org/10.1038/s41467-022-30573-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192778/
https://www.ncbi.nlm.nih.gov/pubmed/35697697
http://dx.doi.org/10.1038/s41467-022-30573-4

Ejemplares similares